DIASORIN MOLECULAR LLC – Trademark Portfolio
Entity Type: 16
DIASORIN MOLECULAR LLC holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 4 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include SIMPLEXA, DX SELECT, HERPESELECT, and FOCUS DIAGNOSTICS. The owner is based in CYPRESS, CA.
11331 VALLEY VIEW STREET
CYPRESS, CA 90630
Showing of trademarks Trademarks
Trademark Classifications
DIASORIN MOLECULAR LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does DIASORIN MOLECULAR LLC have?
DIASORIN MOLECULAR LLC has 7 U.S. trademarks filed with the USPTO. Of these, 6 registered, 1 cancelled.
What trademark classes does DIASORIN MOLECULAR LLC file in?
DIASORIN MOLECULAR LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are DIASORIN MOLECULAR LLC's most well-known trademarks?
DIASORIN MOLECULAR LLC's registered trademark portfolio includes well-known marks such as SIMPLEXA, DX SELECT, HERPESELECT, and FOCUS DIAGNOSTICS. These are among 6 currently registered trademarks in the portfolio.
What is DIASORIN MOLECULAR LLC's trademark registration success rate?
DIASORIN MOLECULAR LLC has a 86% trademark registration rate, with 6 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.